e-learning
resources
Virtual 2020
Pre-Congress Content
Translational science in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
I. LENEVA (Moscow, Russian Federation), I. Falynskova (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria)
Source:
Virtual Congress 2020 – Translational science in respiratory infections
Session:
Translational science in respiratory infections
Session type:
E-poster session
Number:
2338
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. LENEVA (Moscow, Russian Federation), I. Falynskova (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria). Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia. 2338
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Long-term outcomes after viral pneumonia caused by influenza A (H1N1)
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002
Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1
Source: Eur Respir J 2011; 38: 739-742
Year: 2011
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation
Source: Eur Respir J 2011; 37: 44-52
Year: 2011
Bacterial coinfections in swine influenza (H1N1) pneumonia
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
RNA interference against influenza A (H1N1) virus
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic
Source: Eur Respir J 2011; 37: 106-111
Year: 2011
Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model
Source: Eur Respir J 2011; 38: 401-408
Year: 2011
Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Oral presentation: The long-term effect of neonatal respiratory syncytial virus (RSV) infection on the response to adult allergen challenge
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Serial viral infections in infants with recurrent respiratory illnesses
Source: Eur Respir J 2008; 32: 314-320
Year: 2008
Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011
Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Impaired viral clearance after influenza infection in IDO transgenic mice
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept